Skip to main content
Signal8

FISCHER JOST

SEC insider (Form 3/4/5 filer). CIK 0001366841. Director at AEON Biopharma, Inc. (AEON). 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in IRVINE, CA.

Companies FISCHER JOST has filed insider reports for

  • AEON Biopharma, Inc. (AEON): Director
FISCHER JOST profile photo

FISCHER JOST

CIK: 0001366841

Transaction Breakdown

Open Market Buys (P)3 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AEON Biopharma, Inc. logo
AEON

AEON Biopharma, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • AEON Biopharma, Inc. logo
    AEON

    AEON Biopharma, Inc.

    Jun 17, 2026
    Award
    Direct
    222.7K shares-
  • AEON Biopharma, Inc. logo
    AEON

    AEON Biopharma, Inc.

    May 21, 2025
    Award

    Restricted Stock Units

    Direct
    308.6K shares-
  • AEON Biopharma, Inc. logo
    AEON

    AEON Biopharma, Inc.

    May 21, 2025
    Purchase
    Direct
    60K shares at avg. $0.49$29K
  • AEON Biopharma, Inc. logo
    AEON

    AEON Biopharma, Inc.

    May 20, 2025
    Purchase
    Direct
    60K shares at avg. $0.51$30K
  • AEON Biopharma, Inc. logo
    AEON

    AEON Biopharma, Inc.

    May 19, 2025
    Purchase
    Direct
    50K shares at avg. $0.50$25K
  • AEON Biopharma, Inc. logo
    AEON

    AEON Biopharma, Inc.

    Aug 31, 2024
    Award
    Direct
    36K shares-

1-6 of 6